KDM6A Gene

Overview

flowchart TD
    KDM6A["KDM6A"] -->|"demethylates"| H3K27me3["H3K27me3"]
    KDM6A["KDM6A"] -->|"inhibits"| MMP3["MMP3"]
    KDM6A["KDM6A"] -->|"interacts with"| CREB["CREB"]
    KDM6A["KDM6A"] -->|"inhibits"| Spinal_Cord_Injury["Spinal Cord Injury"]
    KDM6A["KDM6A"] -->|"activates"| Tumor["Tumor"]
    KDM6A["KDM6A"] -->|"activates"| Cancer["Cancer"]
    KDM6A["KDM6A"] -->|"activates"| Als["Als"]
    KDM6A["KDM6A"] -->|"activates"| Glioblastoma["Glioblastoma"]
    KDM6A["KDM6A"] -->|"inhibits"| Tumor["Tumor"]
    KDM6A["KDM6A"] -->|"treats"| Prostate_Cancer["Prostate Cancer"]
    KDM6A["KDM6A"] -->|"inhibits"| Cancer["Cancer"]
    KDM6A["KDM6A"] -->|"treats"| Aging["Aging"]
    KDM6A["KDM6A"] -->|"regulates"| Cancer["Cancer"]
    KDM6A["KDM6A"] -->|"regulates"| Lung_Cancer["Lung Cancer"]
    style KDM6A fill:#4fc3f7,stroke:#333,color:#000

KDM6A (Lysine Specific Demethylase 6A), also known as UTX (Ubiquitously Transcribed X chromosome tetratricopeptide repeat containing), is a histone demethylase that catalyzes the removal of methyl groups from trimethylated lysine 27 on histone H3 (H3K27me3)^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}. This epigenetic enzyme is a key regulator of gene expression during development, cellular differentiation, and disease processes. KDM6A belongs to the UTX family of Jumonji C domain-containing demethylases and requires iron (Fe2+) and 2-oxoglutarate as cofactors for its catalytic activity.

In the nervous system, KDM6A plays critical roles in neurodevelopment, synaptic plasticity, and neuronal survival. The enzyme regulates chromatin accessibility at gene promoters and enhancers, thereby controlling the expression of genes essential for neuronal differentiation, learning and memory, and response to cellular stress. Dysregulation of KDM6A has been implicated in multiple neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and neurodevelopmental disorders such as Kabuki syndrome and Rett syndrome

Gene and Protein Structure

Gene Organization

The human KDM6A gene is located on the X chromosome at Xp11.3 and spans approximately 230 kilobases. The gene contains 29 exons and encodes a protein of 1,401 amino acids with a molecular weight of approximately 160 kDa. Notably, KDM6A escapes X-inactivation in females due to partial escape from silencing, resulting in biallelic expression in some tissues.

Protein Domains

The KDM6A protein contains several functional domains:

1. Jumonji C (JmjC) domain: The catalytic domain (~250 amino acids) containing the HxD...H motif required for Fe²⁺ binding and 2-oxoglutarate coordination

2. Tetratricopeptide repeat (TPR) domain: Located at the N-terminus, mediates protein-protein interactions

3. TxG-rich regions: Involved in transcriptional activation

4. Nuclear localization signals (NLS): Directs nuclear import

5. Interaction domains: For binding to transcription factors and chromatin remodeling complexes

Orthologs and Evolution

KDM6A is highly conserved across vertebrates. The mouse ortholog (Kdm6a) shares 96% identity with the human protein. Drosophila has a related gene, dUTX, which also functions in development.

Biological Functions

Histone Demethylase Activity

KDM6A specifically removes the trimethyl group from H3K27me3, converting it to H3K27me2 or H3K27me1^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}:

H3K27me3 →(KDM6A)→ H3K27me2 →(KDM6A)→ H3K27me1

This activity is part of the dynamic regulation of histone methylation states, where H3K27me3 is typically associated with gene silencing. By removing this mark, KDM6A promotes gene activation, particularly at enhancers and promoters of development-specific genes.

Regulation of Gene Expression

KDM6A regulates gene expression through:

• Direct demethylation: Removing repressive H3K27me3 marks from target gene promoters

• Complex formation: Interacting with the MLL3/4 COMPASS complexes to activate gene transcription

• Chromatin remodeling: Recruiting co-activators and facilitating enhancer-promoter interactions

• Developmental gene networks: Controlling Hox genes and other developmental regulators

Cellular Functions

In neurons and neural precursors, KDM6A regulates:

• Neural progenitor cell differentiation: Timing of neuronal versus glial differentiation^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}

• Synaptic plasticity: Expression of synaptic proteins and plasticity-related genes^{3KDM6A regulates expression of synaptic proteins in neurons2020 · Cell Reports · DOI 10.1016/j.celrep.2020.107652Open reference}

• Memory formation: Consolidation of long-term memory through chromatin remodeling^{4Histone demethylase activity of KDM6A in synaptic plasticity and memory formation2021 · Journal of Neuroscience · DOI 10.1523/JNEUROSCI.2103-20.2021Open reference}

• Stress response: Regulation of genes involved in cellular stress and survival

• Neuroinflammation: Control of inflammatory gene expression in microglia^{5KDM6A regulates neuroinflammation through H3K27me3 demethylation in microglia2022 · Glia · DOI 10.1002/glia.24128Open reference}

Expression in the Nervous System

Brain Region Expression

KDM6A is expressed throughout the brain with particularly high levels in:

• Hippocampus — CA1-CA3 pyramidal neurons, dentate gyrus granule cells

• Cerebral cortex — all layers, particularly layer V pyramidal neurons

• Cerebellum — Purkinje cells, granule cells

• Substantia nigra — dopaminergic neurons

• Striatum — medium spiny neurons

Cellular Expression

• Neurons: High expression in excitatory and inhibitory neurons

• Neural progenitor cells: Critical for differentiation timing

• Astrocytes: Moderate expression, role in astrocyte function

• Microglia: Expression in microglia, regulating inflammatory responses^{5KDM6A regulates neuroinflammation through H3K27me3 demethylation in microglia2022 · Glia · DOI 10.1002/glia.24128Open reference}

Developmental Regulation

KDM6A expression is dynamically regulated:

• Embryonic development: High expression in neural tube and developing brain

• Postnatal: Moderate expression with region-specific patterns

• Aging: Altered expression in aged brain, potentially contributing to cognitive decline^{6KDM6A and 5hmC distribution in aging brain: implications for cognitive decline2021 · Aging Cell · DOI 10.1111/acel.13387Open reference}

Role in Neurodegenerative Diseases

Alzheimer’s Disease

KDM6A is significantly implicated in AD pathophysiology through multiple mechanisms^{7KDM6A deficiency accelerates neurodegeneration in models of Alzheimer's disease2020 · Nature Neuroscience · DOI 10.1038/s41593-020-00642-5Open reference}:

Amyloid-beta pathology:

• KDM6A deficiency accelerates amyloid-beta accumulation

• Altered expression of APP processing enzymes

• Dysregulated autophagy related to amyloid clearance

Tau pathology:

• KDM6A regulates tau phosphorylation through epigenetic mechanisms^{8Epigenetic regulation of tau pathology by KDM6A in Alzheimer's disease2020 · Brain · DOI 10.1093/brain/awaa189Open reference}

• H3K27me3 dysregulation at tau-related gene promoters

• Contribution to neurofibrillary tangle formation

Synaptic dysfunction:

• KDM6A deficiency leads to reduced synaptic protein expression^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}0

• Impaired synaptic plasticity and memory formation^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}1

• Synaptic loss in AD models

Neuroinflammation:

• KDM6A in microglia regulates inflammatory gene expression^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}2

• Altered cytokine production in AD brain

• Therapeutic potential of microglial KDM6A modulation^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}3

Therapeutic implications:

• Small molecule activators of KDM6A show neuroprotective effects^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}4

• Preclinical validation of KDM6A-targeted approaches^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}5

• Combined targeting of amyloid and epigenetic pathways

Parkinson’s Disease

In PD, KDM6A plays important roles^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}6:

Dopaminergic neuron survival:

• KDM6A deficiency in dopaminergic neurons contributes to PD pathology^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}7

• Altered expression of survival-related genes

• Mitochondrial dysfunction related to KDM6A dysregulation

Oxidative stress:

• KDM6A regulates antioxidant gene expression

• Vulnerability to oxidative stress in PD

• Interaction with mitochondrial quality control pathways

Neuroinflammation:

• Glial KDM6A modulates neuroinflammation in PD

• Potential therapeutic target for modulating glial responses

Neurodevelopmental Disorders

Kabuki Syndrome:

• KDM6A is one of the two genes (alongside KDM6B) mutated in Kabuki syndrome^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}8

• Haploinsufficiency leads to characteristic neurodevelopmental features

• Intellectual disability, facial dysmorphism, and developmental delay

• Neural crest development defects related to KDM6A function^{1Molecular mechanisms and potential functions of histone demethylases2012 · Nature Reviews Molecular Cell Biology · DOI 10.1038/nrm3337Open reference}9

Rett Syndrome:

• KDM6A deficiency contributes to Rett syndrome phenotypes^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}0

• Dysregulated synaptic gene expression

• Impaired neuronal connectivity

Other conditions:

• Developmental delays and intellectual disability

• Autism spectrum disorder associated features

• Epilepsy in some patients

Molecular Mechanisms

Signaling Pathways

KDM6A interacts with several signaling pathways:

• Notch signaling: KDM6A regulates Notch target gene expression

• Wnt/β-catenin: Modulates Wnt target gene activation

• p53 pathway: Interacts with p53-mediated transcription

• NF-κB: Regulates inflammatory gene expression

• MAPK/ERK: Activity modulates neuronal survival

Protein Interactions

KDM6A interacts with multiple protein complexes:

• MLL3/4 COMPASS complexes: H3K4 methyltransferases for gene activation

• UTAF1 complex: Novel complex for H3K27 demethylation

• SWI/SNF complexes: Chromatin remodeling for accessibility

• Transcription factors: Direct interaction with tissue-specific factors

Epigenetic Regulation

KDM6A-mediated H3K27me3 demethylation affects:

• Enhancer activation: Opening of cell-type specific enhancers

• Polycomb replacement: Counteracting PRC2-mediated silencing

• Developmental timing: Coordinating gene expression programs

• Disease-specific patterns: Aberrant H3K27me3 in neurodegeneration

Therapeutic Implications

Therapeutic Targets

KDM6A represents a promising therapeutic target for neurodegenerative diseases^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}1:

1. KDM6A activators: Small molecules that enhance KDM6A activity

2. Epigenetic modulators: Broader epigenetic drugs affecting KDM6A pathways

3. Gene therapy: Viral vector-mediated KDM6A expression

4. Combination approaches: Combined with anti-amyloid or anti-tau strategies

Drug Development

Several strategies are being explored^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}2:

• Small molecule activators: Development of KDM6A-specific activators

• Natural compounds: Investigation of dietary polyphenols

• Targeted delivery: Nanoparticle-based delivery to neurons

• Biomarker development: Identifying patients who may benefit from KDM6A-targeted therapy

Challenges and Considerations

• Broad substrate specificity: KDM6A affects many genes

• X-chromosome location: Implications for dosing and side effects

• Tissue-specific delivery: Ensuring CNS penetration

• Biomarker development: Patient selection for clinical trials

Key Research Findings

1. KDM6A is required for neural crest development and its deficiency causes Kabuki syndrome phenotypes^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}3

2. UTX-mediated demethylation regulates neuronal differentiation and developmental timing^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}4

3. KDM6A deficiency accelerates neurodegeneration in AD models^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}5

4. KDM6A activity is required for synaptic plasticity and memory formation^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}6

5. KDM6A regulates neuroinflammation through H3K27me3 demethylation in microglia^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}7

6. KDM6A mutation in Kabuki syndrome leads to neurodevelopmental deficits^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}8

7. KDM6A regulates tau pathology through epigenetic mechanisms in AD^{2KDM6A coordinates with PRC2 to regulate neural progenitor cell differentiation2020 · Development · DOI 10.1242/dev.188888Open reference}9

8. KDM6A deficiency in dopaminergic neurons contributes to PD pathology^{3KDM6A regulates expression of synaptic proteins in neurons2020 · Cell Reports · DOI 10.1016/j.celrep.2020.107652Open reference}0

9. Small molecule activators of KDM6A show neuroprotective effects in preclinical models^{3KDM6A regulates expression of synaptic proteins in neurons2020 · Cell Reports · DOI 10.1016/j.celrep.2020.107652Open reference}1

Cross-References

• Histone Methylation Mechanisms

• Epigenetics in Neurodegeneration

• Chromatin Remodeling

• Alzheimer’s Disease

• Parkinson’s Disease

• Kabuki Syndrome

• KDM6B Gene

• MLL3 Gene

• MLL4 Gene

External Links

• NCBI Gene: KDM6A

• UniProt: UTX (O43509)

• OMIM: 300128

• Ensembl: ENSG00000102038

• GeneCards: KDM6A

• PubMed: KDM6A neurodegeneration